Ten Bay Bio

Milwaukee, WI · Founded 2024 · Privately Held (backing)

Provider of biological therapies intended to address complex diseases in immunology. Ten Bay Bio is based in Milwaukee, WI and was founded in 2024. It has raised $11.6 million across 1 recorded round; the latest was an $11.5 million early-stage round in Jul 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$11.6M
Last round
Early Stage VC
Jul 2024
How much has Ten Bay Bio raised?
$11.6Macross 1 recorded rounds · Jul 2024 – Jul 2024

Most recently, Ten Bay Bio raised $11.5M in its Early Stage VC (Jul 2024).

Free account
More of Ten Bay Bio with a free account
  • ·Watch Ten Bay Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ten Bay Bio round by round

1 rounds
Jul 2024Early Stage VC$11.5MSEC filing▮
6 investors participated

How much has Ten Bay Bio raised?

Ten Bay Bio has raised $11.6 million across 1 recorded round since 2024. The largest was an $11.5 million early-stage round in Jul 2024.

Ten Bay Bio has filed 2 Form Ds with the SEC since 2024, most recently in May 2025 ($11.5 million sold to 6 investors).

Ten Bay Bio investors

3 investors are on record for Ten Bay Bio, including Wisconsin Investment Management Company, Santé Ventures and Venture Investors Health Fund. The early-stage round in Jul 2024 drew 6 investors.

For fundraisers
Raising for a company like Ten Bay Bio?

3 investors have backed Ten Bay Bio.

See all 3 investors →

Frequently asked about Ten Bay Bio

How much has Ten Bay Bio raised?
Ten Bay Bio has raised $11.6M in total across 1 recorded funding rounds.
When was Ten Bay Bio's last funding round?
Ten Bay Bio's most recent recorded round was Early Stage VC in Jul 2024, raising $11.5M.